// company-profile

GT Biopharma, Inc.

GTBP
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings11Insiders6
// api This GT Biopharma, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

No insider transactions in the last 30 days.

No insider activity recorded for GTBP in the last 90 days.

Institutional Ownership

Top 13F-HR holders of GT Biopharma, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$538,391
QoQ change
+61.6%
Reporting period
2026-03-31
#1
VANGUARD CAPITAL MANAGEMENT LLC
CIK 2100119
$184,365
452K shares
#2
GEODE CAPITAL MANAGEMENT, LLC
CIK 1214717
$106,626
261K shares
#3
Arax Advisory Partners
CIK 1586767
$38,210
94K shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Sep 4, 2025Breen Michael MartinGTBP
Award
100,000$0.00$0K
Sep 4, 2025CASAMENTO CHARLES JGTBP
Award
62,500$0.00$0K
Sep 4, 2025Breen Michael MartinGTBP
Award
100,000$0.00$0K
Sep 4, 2025Breen Michael MartinGTBP
Award
100,000$0.00$0K
Sep 4, 2025Kramer HilaryGTBP
Award
31,250$0.00$0K

11 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.